XML 30 R16.htm IDEA: XBRL DOCUMENT v3.24.1
STOCK COMPENSATION PLANS
12 Months Ended
Dec. 30, 2023
STOCK COMPENSATION PLANS  
STOCK COMPENSATION PLANS

NOTE 10 – STOCK COMPENSATION PLANS

 

The Company’s 2021 Long Term Incentive Plan (the “Long Term Incentive Plan”), currently provides for the aggregate issuance of up to 1,500,000 shares of common stock. The Long Term Incentive Plan provides for grants of non-statutory options, incentive stock options, restricted stock awards, performance shares, performance units, restricted stock units and other stock-based awards, in order to enhance the ability of ENGlobal to motivate current employees, to attract employees of outstanding ability and to provide for grants to be made to non-employee directors. At December 30, 2023, 5,376 shares of common stock are available to be issued pursuant to the Long Term Incentive Plan.

 

We recognized non-cash stock-based compensation expense related to our Long Term Incentive Plan and the expired Amended and Restated 2009 Equity Incentive Plan of $0.3 million for the year ended December 30, 2023 and $0.2 million for the year ended December 31, 2022.

Restricted Stock Awards Restricted stock awards granted to non-employee directors are intended to compensate and retain the directors over the one-year service period commencing July 1 of the year of service. These awards generally vest in quarterly installments beginning September 30th of the year of grant, so long as the grantee continues to serve as a director of the Company as of each vesting date. In 2023, members of the Board of Directors received additional restricted stock awards in lieu of a cash payment for compensation of their service.

 

Restricted stock awards granted to employees generally vest in four equal annual installments on the anniversary date of grant, so long as the grantee remains employed full-time with us as of each vesting date. Restricted stock awards are generally issued as new shares at the time of grant. The grant-date fair value of restricted stock grants is determined using the closing quoted market price on the grant date. The restricted shares and weighted-average grant-date fair value has been recast to reflect the one-for-eight reverse stock split effected on November 30, 2023.

 

The following is a summary of the status of our restricted stock awards and of changes in restricted stock outstanding for the year ended December 30, 2023:

 

 

 

Number of

unvested restricted

shares

 

 

Weighted-average grant-date fair

value

 

Outstanding at December 31, 2022

 

 

11,622

 

 

$19.20

 

Granted

 

 

155,235

 

 

 

5.19

 

Vested

 

 

48,050

 

 

 

2.80

 

Forfeited

 

 

1,818

 

 

 

34.42

 

Outstanding at December 30, 2023

 

 

116,989

 

 

$2.96

 

 

As of December 30, 2023, there was $0.3 million of total unrecognized compensation cost related to unvested restricted stock awards which is expected to be recognized over a weighted-average period of 1.4 years.

 

During the year ended December 30, 2023, the Company granted the following restricted stock awards:

 

Date Issued

 

Issued to

 

Number of Shares

 

 

Market Price

 

 

Fair Value

 

July 12, 2023

 

Directors (5)

 

 

142,860

 

 

$2.80

 

 

$400,008

 

August 9, 2023

 

Employees (4)

 

 

12,375

 

 

 

2.80

 

 

 

34,650

 

 

                During the year ended December 31, 2022, the Company granted the following restricted stock awards:

 

Date Issued

 

Issued to

 

Number of Shares

 

 

Market Price

 

 

Fair Value

 

June 9, 2022

 

Director (3)

 

 

14,313

 

 

$10.48

 

 

$150,000